Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
3.300
-0.220 (-6.25%)
At close: Feb 21, 2025, 4:00 PM
3.340
+0.040 (1.21%)
After-hours: Feb 21, 2025, 4:23 PM EST
Amylyx Pharmaceuticals Employees
Amylyx Pharmaceuticals had 384 employees as of December 31, 2023. The number of employees increased by 122 or 46.56% compared to the previous year.
Employees
384
Change (1Y)
122
Growth (1Y)
46.56%
Revenue / Employee
$511,680
Profits / Employee
-$675,693
Market Cap
224.67M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 384 | 122 | 46.56% |
| Dec 31, 2022 | 262 | 57 | 27.80% |
| Dec 31, 2021 | 205 | 171 | 502.94% |
| Dec 31, 2020 | 34 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
AMLX News
- 8 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Amylyx Pharmaceuticals, Inc. (AMLX) Shareholders to Inquire about Securities Investigation - Accesswire
- 9 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Shareholders to Connect - Accesswire
- 10 days ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Shareholders to Reach Out - Accesswire
- 11 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Amylyx Pharmaceuticals, Inc. (AMLX) and Encourages Shareholders to Learn More About the Investigation - Accesswire
- 12 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Amylyx Pharmaceuticals, Inc. (AMLX) Stockholders to Inquire about Securities Investigation - Accesswire
- 12 days ago - Amylyx Pharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Business Wire
- 13 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Amylyx Pharmaceuticals, Inc. (AMLX) and Encourages Investors to Learn More About the Investigation - Accesswire
- 15 days ago - Amylyx Pharmaceuticals, Inc. (AMLX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Accesswire